Literature DB >> 7311560

Protein binding of methotrexate in sera from normal human beings: effect of drug concentration, pH, temperature, and storage.

J W Paxton.   

Abstract

Ultrafiltration through dialysis tubing was used to assess factors influencing methotrexate (MTX) binding to serum proteins. Determinations of percentage bound by this method either using addition of radioactive tracer or measuring absolute concentrations by radioimmunoassay were not significantly different. Likewise, similar values were obtained using equilibrium dialysis and ultracentrifugation for assessment of percentage bound. Reduction in the pH of serum from 7.9 to 7.2 resulted in a significant decrease in binding, whereas reduction in temperature from 37 to 21 degrees C resulted in a significant increase. Binding was also observed to decrease significantly in serum samples containing MTX that had been stored frozen at -20 degrees C for a month. No significant reduction in the percentage bound was observed on increasing MTX concentration from 10(-10) M until it had risen to 10(-4)--10(-3) M. Analysis at 37 degrees C of fresh sera with 10(-6) M MTX added and pH 7.4 from 19 healthy volunteers gave a mean percentage bound 46.5 +/- 2.7 (SD) with range 41.5-51.0%. No significant difference was found between males and females, and no significant linear correlations were observed between the extent of binding with serum concentrations of total proteins, albumin, total bilirubin or triglycerides, or with age.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7311560     DOI: 10.1016/0160-5402(81)90088-7

Source DB:  PubMed          Journal:  J Pharmacol Methods        ISSN: 0160-5402


  8 in total

1.  Urinary pH and urine flow independent renal clearance of methotrexate in dogs.

Authors:  C Y Lui; M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1985-04

2.  Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits.

Authors:  H Iven; H Brasch
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Lack of correlation between methotrexate concentrations in serum, saliva and sweat after 24 h methotrexate infusions.

Authors:  H Schrøder; K B Jensen; M Brandsborg
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

5.  Pharmacokinetics of different doses of methotrexate at steady state by in situ microdialysis in a rat model.

Authors:  P O Ekstrøm; A Anderson; D J Warren; K E Giercksky; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

6.  Biochemical and pharmacological consequences of the interaction between methotrexate and ketoprofen in the rabbit.

Authors:  A Perrin; G Milano; A Thyss; P Cambon; M Schneider
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

7.  Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy.

Authors:  Xiaoyu Tu; Ruizhe Chen; Baohua Li; Genping Huang; Nanjia Lu; Qin Chen; Xiaoxia Bai
Journal:  Cancer Manag Res       Date:  2020-06-02       Impact factor: 3.989

Review 8.  Methotrexate an Old Drug with New Tricks.

Authors:  Yosra Bedoui; Xavier Guillot; Jimmy Sélambarom; Pascale Guiraud; Claude Giry; Marie Christine Jaffar-Bandjee; Stéphane Ralandison; Philippe Gasque
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.